Clinical Trial Update: Refractory Ascitis Diagnosis by the Study of Labelled Albumin Pharmacokinetics [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on diagnosing refractory ascites in cirrhosis patients using labelled albumin pharmacokinetics; status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ascites
• Cirrhosis

Drugs mentioned

• Labelled albumin (pharmacokinetic tracer) (albumin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Refractory Ascites in Patients With Cirrhosis | Phase 3 | Status: UNKNOWN